Literature DB >> 24529992

Vitamin D metabolism, mechanism of action, and clinical applications.

Daniel D Bikle1.   

Abstract

Vitamin D3 is made in the skin from 7-dehydrocholesterol under the influence of UV light. Vitamin D2 (ergocalciferol) is derived from the plant sterol ergosterol. Vitamin D is metabolized first to 25 hydroxyvitamin D (25OHD), then to the hormonal form 1,25-dihydroxyvitamin D (1,25(OH)2D). CYP2R1 is the most important 25-hydroxylase; CYP27B1 is the key 1-hydroxylase. Both 25OHD and 1,25(OH)2D are catabolized by CYP24A1. 1,25(OH)2D is the ligand for the vitamin D receptor (VDR), a transcription factor, binding to sites in the DNA called vitamin D response elements (VDREs). There are thousands of these binding sites regulating hundreds of genes in a cell-specific fashion. VDR-regulated transcription is dependent on comodulators, the profile of which is also cell specific. Analogs of 1,25(OH)2D are being developed to target specific diseases with minimal side effects. This review will examine these different aspects of vitamin D metabolism, mechanism of action, and clinical application.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24529992      PMCID: PMC3968073          DOI: 10.1016/j.chembiol.2013.12.016

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  126 in total

1.  Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone.

Authors:  Mark B Meyer; Paul D Goetsch; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-18       Impact factor: 4.292

2.  Vitamin D and prevention of cancer--ready for prime time?

Authors:  JoAnn E Manson; Susan T Mayne; Steven K Clinton
Journal:  N Engl J Med       Date:  2011-03-23       Impact factor: 91.245

3.  Vitamin D analogues targeting CYP24 in chronic kidney disease.

Authors:  Gary H Posner; Christian Helvig; Dominic Cuerrier; Drew Collop; Aza Kharebov; Kara Ryder; Tina Epps; Martin Petkovich
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-27       Impact factor: 4.292

4.  Mutations in CYP24A1 and idiopathic infantile hypercalcemia.

Authors:  Karl P Schlingmann; Martin Kaufmann; Stefanie Weber; Andrew Irwin; Caroline Goos; Ulrike John; Joachim Misselwitz; Günter Klaus; Eberhard Kuwertz-Bröking; Henry Fehrenbach; Anne M Wingen; Tülay Güran; Joost G Hoenderop; René J Bindels; David E Prosser; Glenville Jones; Martin Konrad
Journal:  N Engl J Med       Date:  2011-06-15       Impact factor: 91.245

5.  Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.

Authors:  Joanna Mitri; Bess Dawson-Hughes; Frank B Hu; Anastassios G Pittas
Journal:  Am J Clin Nutr       Date:  2011-06-29       Impact factor: 7.045

Review 6.  Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis.

Authors:  Mohammad Hassan Murad; Khalid B Elamin; Nisrin O Abu Elnour; Mohamed B Elamin; Aziz A Alkatib; Mitra M Fatourechi; Jaime P Almandoz; Rebecca J Mullan; Melanie A Lane; Hau Liu; Patricia J Erwin; Donald D Hensrud; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2011-07-27       Impact factor: 5.958

Review 7.  Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.

Authors:  Mark R Haussler; Peter W Jurutka; Mathew Mizwicki; Anthony W Norman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-08       Impact factor: 4.690

Review 8.  Vitamin D analogs.

Authors:  Glenville Jones
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

9.  A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

Authors:  Sreeram V Ramagopalan; Andreas Heger; Antonio J Berlanga; Narelle J Maugeri; Matthew R Lincoln; Amy Burrell; Lahiru Handunnetthi; Adam E Handel; Giulio Disanto; Sarah-Michelle Orton; Corey T Watson; Julia M Morahan; Gavin Giovannoni; Chris P Ponting; George C Ebers; Julian C Knight
Journal:  Genome Res       Date:  2010-08-24       Impact factor: 9.043

10.  Mapping and analysis of chromatin state dynamics in nine human cell types.

Authors:  Jason Ernst; Pouya Kheradpour; Tarjei S Mikkelsen; Noam Shoresh; Lucas D Ward; Charles B Epstein; Xiaolan Zhang; Li Wang; Robbyn Issner; Michael Coyne; Manching Ku; Timothy Durham; Manolis Kellis; Bradley E Bernstein
Journal:  Nature       Date:  2011-03-23       Impact factor: 49.962

View more
  387 in total

1.  SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D3 signaling via vitamin D receptor deacetylation.

Authors:  Marya S Sabir; Zainab Khan; Chengcheng Hu; Michael A Galligan; Christopher M Dussik; Sanchita Mallick; Angelika Dampf Stone; Shane F Batie; Elizabeth T Jacobs; G Kerr Whitfield; Mark R Haussler; Michael C Heck; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2017-06-19       Impact factor: 4.292

2.  A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major.

Authors:  M Dimitriadou; A Christoforidis; L Fidani; M Economou; E Vlachaki; M Athanassiou-Metaxa; G Katzos
Journal:  Osteoporos Int       Date:  2015-08-15       Impact factor: 4.507

3.  Associations of serum perfluoroalkyl substance and vitamin D biomarker concentrations in NHANES, 2003-2010.

Authors:  Taylor M Etzel; Joseph M Braun; Jessie P Buckley
Journal:  Int J Hyg Environ Health       Date:  2018-11-28       Impact factor: 5.840

Review 4.  New developments in our understanding of vitamin metabolism, action and treatment.

Authors:  Sylvia Christakos; Shanshan Li; Jessica De La Cruz; Daniel D Bikle
Journal:  Metabolism       Date:  2019-06-19       Impact factor: 8.694

5.  Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3.

Authors:  Chloe Y S Cheng; Tae-Kang Kim; Saowanee Jeayeng; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-14       Impact factor: 4.292

6.  Vitamin D supplementation may improve symptoms in Meniere's disease.

Authors:  Bela Büki; Heinz Jünger; Yunxia Wang Lundberg
Journal:  Med Hypotheses       Date:  2018-04-24       Impact factor: 1.538

7.  In vitro and in vivo roles of glucocorticoid and vitamin D receptors in the control of neonatal cardiomyocyte proliferative potential.

Authors:  Stephen Cutie; Alexander Y Payumo; Dominic Lunn; Guo N Huang
Journal:  J Mol Cell Cardiol       Date:  2020-04-11       Impact factor: 5.000

Review 8.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

9.  The possible antidiabetic effects of vitamin D receptors agonist in rat model of type 2 diabetes.

Authors:  Wafaa M Abdel-Rehim; Rasha A El-Tahan; Mennatullah A El-Tarawy; Rowaida R Shehata; Maher A Kamel
Journal:  Mol Cell Biochem       Date:  2018-06-16       Impact factor: 3.396

10.  Acute hepatologic and nephrologic effects of calcitriol in Syrian golden hamster (Mesocricetus auratus).

Authors:  Ewa Podgorska; Martyna Sniegocka; Marianna Mycinska; Wojciech Trybus; Ewa Trybus; Anna Kopacz-Bednarska; Olga Wiechec; Martyna Krzykawska-Serda; Martyna Elas; Teodora Krol; Krystyna Urbanska; Andrzej Slominski
Journal:  Acta Biochim Pol       Date:  2018-07-17       Impact factor: 2.149

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.